英文名称 | 中文名称 | CAS | MF |
ROX-DDUTP
|
|
|
|
RPM-1 protein
|
|
|
|
Roxibolone
|
罗昔勃龙
|
60023-92-9
|
C21H28O5
|
roxifiban
|
|
176022-59-6
|
|
ROXINDOLE MESYLATE
|
|
119742-13-1
|
C24H30N2O4S
|
RPMS protein
|
|
|
|
30-[(R)-Oxiran-2-yl]-5α-lanost-7-en-3β-ol
|
|
|
|
(R)-Oxirane-2-carboxylic acid
|
|
|
|
19-[(R)-Oxiran-2-yl]androst-4-ene-3,17-dione
|
|
|
|
4-[(R)-Oxiranylmethoxy]benzeneacetic acid methyl ester
|
|
|
|
(2R)-Oxirane-2α-acetic acid 2,2,2-trichloroethyl ester
|
|
|
|
2-[[(2R)-Oxirane-2β-yl]methoxy]tetrahydro-2H-pyran
|
|
|
|
(R)-Oxirane-2-propionic acid ethyl ester
|
|
|
|
(1R)-1-Oxiranyl-1-hexanol
|
|
|
|
1-[(2R)-Oxiran-2-yl]-4-[(2S)-oxiran-2-yl]butane
|
|
|
|
(R)-1-(Oxirane-2α-yl)-2-propene-1-ol
|
|
|
|
(S)-Oxiranemethanol
|
(S)-缩水甘油
|
60456-23-7
|
C3H6O2
|
(R)-3-(OXIRAN-2-YLMETHOXY)BENZONITRILE
|
|
|
C10H9NO2
|
(R)-4-(OXIRAN-2-YLMETHOXY)BENZONITRILE
|
|
70987-79-0
|
C10H9NO2
|
(R)-2-(OXIRAN-2-YLMETHOXY)BENZONITRILE
|
|
93744-17-3
|
C10H9NO2
|
5-(R)-OXIRANYL-2-PHENYLACETOXY-BENZOIC ACID METHYL ESTER
|
|
|
C18H16O5
|
(+)-3-[[(R)-2-(p-Nitrobenzoyloxy)-4-hydroxy-3,3-dimethyl-1-oxobutyl]amino]propanoic acid
|
|
|
|
[R,(+)]-2-(p-Nitrophenyl)propionic acid sodium salt
|
|
|
|
[R,(-)]-2-(p-Nitrophenyl)peroxypropionic acid
|
|
|
|
[R,(-)]-p-Nitrohydratropic acid
|
|
|
|
[R,(-)]-2-(p-Nitrophenyl)propionic acid methyl ester
|
|
|
|
ROXITHROMYCIN LACTOBIONATE
|
|
305831-46-3
|
C41H76N2O15.C12H22O12
|
Roxithromycin soluble
|
|
|
|
Roxithromycin
|
罗红霉素
|
80214-83-1
|
C41H76N2O15
|
ROXITHROMYCIN EPR(CRM STANDARD)
|
|
|
|
ROXITHROMYCIN DIHYDRATE
|
|
|
|
Roxitromycin
|
|
|
|
(R)--(p-Nitrophenyl)alanine
|
|
|
C9H10N2O4
|
(R)-3-(P-NITROPHENYL)-BETA-ALANINE
|
(R)-3-氨基-3-(4-硝基苯基)丙酸
|
501120-99-6
|
C9H10N2O4
|
ROXITHROMYCIN FOR SYSTEM SUITABILITY EPY(CRM STANDARD)
|
|
|
|
RoxithromycnBp/Ep/Usp(OpenPartDmf)
|
|
|
|
Roxithromycin granules
|
|
|
|
Roxithromycin Tablets
|
|
|
|
ROYAL JELLY POWDER (F/D) 10-HAD 6%
|
|
|
|
Royal Jelly Lyophilized Powder
|
蜂王浆冻干粉
|
|
|
Royal Jelly (Fresh&powder)
|
|
|
|
Royal Jelly, 3.5:1, 5-6% HDA, Powder, 40-100 Mesh
|
|
|
|
Royal Jelly, 3:1, 1.6% HDA, Powder, 40-100 Mesh
|
|
|
|
royal jelly protein 3
|
|
|
|
royalisin
|
|
128906-89-8
|
|
Royal Jelly Powder (6%)
|
|
|
|
Royal Jelly Powder (9%)
|
|
|
|
Royal Jelly Powder (2%)
|
|
|
|
ROYALGALAAPPLE
|
|
|
|
ROYALJELLY,3.5:1,5-6%HDA,POWDER
|
|
|
|
ROYALJELLY,3:1,1.6%HDA,POWDER
|
|
|
|
Royal Jelly
|
蜂王浆
|
8031-67-2
|
|
Royal gold DY-303
|
|
|
|
Royal deep gold DY-313
|
|
|
|
Royal gold satin DY-323
|
|
|
|
Royal red golden DY-319
|
|
|
|
RoyalJelly6%10-Had,SecretionOfThePharyngealGlandsOfWorkerBees
|
|
|
|
RoyalJelly3X,SecretionOfThePharyngealGlandsOfWorkerBees
|
|
|
|
RoyalJelly1X,SecretionOfThePharyngealGlandsOfWorkerBees
|
|
|
|
rpoB1 protein
|
|
147651-70-5
|
|
rpoB protein
|
|
|
|
rpoC gene product
|
|
|
|
rpoDA protein
|
|
137701-09-8
|
|
RQ1 DNASE
|
|
|
|
rpoC2 protein
|
|
147651-75-0
|
|
(4R)-2-Oxo-3,4aβ-dimethyl-4α-hydroxy-2,4,4a,5,6,7,8,8aβ,9,9aβ-decahydronaphtho[2,3-b]furan-5β-carboxylic acid lactone
|
|
58947-65-2
|
|
(5R)-7-Oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt
|
|
87395-86-6
|
|
(5R)-7-Oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (4-nitrophenyl)methyl ester
|
|
75468-46-1
|
|
(4R)-2-[(17-Oxoandrost-5-en-3β-yl)oxy]-4-[(hexadecyloxy)methyl]-1,3,2-dioxaphospholane-2-thione
|
|
|
|
(4R)-2-[(17-Oxoandrost-5-en-3β-yl)oxy]-4-(ethoxymethyl)-1,3,2-dioxaphospholane-2-thione
|
|
|
|
(4R)-4-(3-Oxo-1-buten-1-ylidene)-3α,5,5-trimethylcyclohexane-1α,3β-diol
|
|
|
|
(R)-5-OXO-2,3,5,9B-TETRAHYDRO-THIAZOLO[2,3-A]ISOINDOLE-3-CARBOXYLIC ACID
|
|
|
C11H9NO3S
|
2-[(5R)-3-Oxo-1-cyclopenten-5-yl]-2-[[(5R)-5-(2,2-dimethoxyethyl)-3-methyl-2,5-dihydrofuran]-4-yl]acetic acid methyl ester
|
|
|
|
(7R)-7β-(5-Oxo-5-carboxyvalerylamino)-3-(acetoxymethyl)cepham-3-ene-4-carboxylic acid
|
|
|
|
3-[3-[(R)-2-Oxocyclohexyl]propionyl]oxazolidin-2-one
|
|
|
|
2-[(5R)-3-Oxo-1-cyclopenten-5-yl]malonic acid 1-methyl 3-tert-butyl ester
|
|
|
|
α-[(R)-3-Oxocyclohexyl]propiophenone
|
|
|
|
(1R)-4-Oxocyclopentane-1β,2β-dicarboxylic acid dimethyl ester
|
|
|
|
(5R)-7-Oxo-6-[(5,6-dimethyl-1,2,4-triazin-3-yl)methylene]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt
|
|
|
|
(1R)-2-Oxo-3,4-dehydroneomajucin
|
|
|
|
(3R)-5-Oxo-3,5-diphenylvaleric acid tert-butyl ester
|
|
|
|
3-[[(3R)-2-Oxo-1,4α-diphenylazetidin-3α-yl]aminocarbonyl]propionic acid methyl ester
|
|
|
|
(2R)-4-Oxo-5,5-dimethyl-2-[2-oxo-2-(2-oxooxazolidin-3-yl)ethyl]hexanoic acid methyl ester
|
|
|
|
(23R,9β)-3-Oxo-23,27-dihydroxy-5α-lanosta-7,24-dien-26-oic acid 26,23-lactone
|
|
|
|
(22R)-1-Oxo-4β,22-dihydroxy-5,6β-epoxy-5β-ergosta-2,14,24-triene-26-oic acid δ-lactone
|
|
33903-26-3
|
|
(8R)-19-Oxo-15,16:19,20-diepoxylabda-13(16),14-diene-6β,9-diol 6-acetate
|
|
51419-49-9
|
|
(5R)-7-Oxo-6-[(2,4-dimethyloxazol-5-yl)methylene]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt
|
|
|
|
(2R)-1,2α-(10-Oxo-5,9-diazaicosane-1,20-diyl)piperidine
|
|
21008-80-0
|
|
(1R)-3-Oxo-2,2-dimethylcyclobutane-1-acetic acid methyl ester
|
|
|
|
(20R)-3-Oxo-D:C-friedoolean-8-en-29-oic acid
|
|
24480-44-2
|
|
(22R)-1-Oxo-6α,7α-epoxy-5α,20,22-trihydroxy-5α-ergost-2-en-26-oic acid δ-lactone
|
|
|
|
[R,(-)]-2-(2-Oxoethoxy)-2-methoxyacetaldehyde
|
|
|
|
(5R)-7-Oxo-6-[(5-ethyl-1-methyl-1H-pyrazol-3-yl)methylene]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt
|
|
|
|
(5R)-7-Oxo-6-ethylidene-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt
|
|
|
|
(18R)-5-Oxo-14,18-epoxy-3,4-didehydroophiobola-7,19-diene-25-al
|
ANHYDROOPHIOBOLIN A
|
6026-65-9
|
|
(22R)-1-Oxo-6α,7α-epoxy-5,12α,22,27-tetrahydroxy-5α-ergosta-2,24-dien-26-oic acid 26,22-lactone
|
|
|
|
(22R)-1-Oxo-6α,7α-epoxy-5α,14α,20,22-tetrahydroxy-5α-ergost-2-en-26-oic acid δ-lactone
|
|
|
|
(22R)-1-Oxo-6α,7α-epoxy-5α,17α,20,22-tetrahydroxy-5α-ergosta-2,24-dien-26-oic acid δ-lactone
|
|
|
|
(22R)-1-Oxo-6α,7α-epoxy-5α,14α,22-trihydroxy-5α-ergost-2-en-26-oic acid δ-lactone
|
|
|
|
(5R)-7-Oxo-6-[(2-furanyl)methylene]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt
|
|
|
|